77 results
424B2
PLSE
Pulse Biosciences Inc
4 Jun 24
Prospectus for primary offering
4:05pm
to be scraped off by the surgeon during the procedure. Again, this should not be an issue with CellFX nsPFA ablation given its nonthermal nature. Also … to the relevant essential requirements through a conformity assessment procedure. The nature of the assessment depends upon the classification
POS AM
PLSE
Pulse Biosciences Inc
28 May 24
Prospectus update (post-effective amendment)
5:19pm
by the surgeon during the procedure. Again, this should not be an issue with CellFX nsPFA ablation given its nonthermal nature. Also, because nsPFA … to the relevant essential requirements through a conformity assessment procedure. The nature of the assessment depends upon the classification of the device
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
20 May 24
Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000
4:10pm
over current treatment options, statements concerning the timing and nature of the Company’s pilot program to optimize and introduce the CellFX nsPFA
8-K
EX-10.3
PLSE
Pulse Biosciences Inc
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
, WITH OR WITHOUT CAUSE.
9. Nature of Grant. In accepting the Option, Participant acknowledges, understands and agrees that:
(a) the grant of the Option … a description of the Plan. Participant understands that the Plan is discretionary in nature and may be amended, suspended or terminated by the Company at any
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
9 May 24
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
9:09am
, statements concerning the timing and nature of the Company’s pilot program to optimize and introduce the CellFX nsPFA percutaneous procedure
8-K
EX-99.1
8nkf9mzn
2 Jan 24
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
9:20am
8-K
ui59ckujk91jhojartn
27 Nov 23
Regulation FD Disclosure
9:08am
8-K
EX-99.1
vye0rbnbtjg4 ao5
21 Nov 23
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
9:03am